Table 5.
Antimicrobial resistance patterns of the tested C. jejuni isolates against 9 antimicrobial agents of 6 antimicrobial class.
| Resistance pattern | Antimicrobial class | No of resistance isolates (%) |
|---|---|---|
| GEN, AZI, ERY, FLO, CIP, NAL, TET, CM, | Aminoglycoside, Macrolide, Phenicol, Quinolones, Tetracycline, Lincosamides | 1 (2.27%) |
| GEN, AZI, ERY, FLO, CIP, NAL, TET, | Aminoglycoside, Macrolide, Phenicol, Quinolones, Tetracycline | 1 (2.27%) |
| GEN, AZI, ERY, CIP, NAL, TET, CM, | Aminoglycoside, Macrolide, Quinolones, Tetracycline, Lincosamides | 1 (2.27%) |
| GEN, AZI, CIP, NAL, TET, CM, | Aminoglycoside, Macrolide, Quinolones, Tetracycline, Lincosamides | 1 (2.27%) |
| AZI, ERY, CIP, NAL, TET, CM, | Macrolide, Quinolones, Tetracycline, Lincosamides | 2 (4.54%) |
| GEN, AZI, CIP, NAL, CM, | Aminoglycoside, Macrolide, Quinolones, Lincosamides | 1 (2.27%) |
| GEN, AZI, CIP, NAL, | Aminoglycoside, Macrolide, Quinolones | 1 (2.27%) |
| AZI, ERY, TET, CM, | Macrolide, Tetracycline, Lincosamides | 1 (2.27%) |
| CIP, NAL, TET | Quinolones, Tetracycline | 2 (4.54%) |
| AZI, CM | Lincosamides Macrolide | 1 (2.27%) |
| TET | Tetracycline | 4 (9.09%) |
| NAL | Quinolones | 1 (2.27%) |
| CM | Lincosamides | 1 (2.27%) |
| None | None | 26 (59.09%) |
Abbreviations: AZI, azithromycin; CIP, ciprofloxacin; CM, clindamycin; ERY, erythromycin; FLO, florfenicol; GEN, gentamycin; NAL, nalidixic acid; TET, tetracycline.